BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17448572)

  • 1. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients.
    Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
    Neurobiol Aging; 2008 Oct; 29(10):1474-84. PubMed ID: 17448572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
    Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
    Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
    Sala SG; Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
    J Pharmacol Exp Ther; 2008 Jan; 324(1):352-9. PubMed ID: 17928568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the na+/H+ exchanger.
    Urcelay E; Ibarreta D; Parrilla R; Ayuso MS; Martín-Requero A
    Neurobiol Dis; 2001 Apr; 8(2):289-98. PubMed ID: 11300724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
    Levitt RJ; Zhao Y; Blouin MJ; Pollak M
    Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts.
    Cavazzin C; Bonvicini C; Nocera A; Racchi M; Kasahara J; Tardito D; Gennarelli M; Govoni S; Racagni G; Popoli M
    Neurobiol Aging; 2004 Oct; 25(9):1187-96. PubMed ID: 15312964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+/calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia.
    de las Cuevas N; Urcelay E; Hermida OG; Saíz-Diaz RA; Bermejo F; Ayuso MS; Martín-Requero A
    Neurobiol Dis; 2003 Aug; 13(3):254-63. PubMed ID: 12901840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.
    Auld CA; Morrison RF
    Obesity (Silver Spring); 2006 Dec; 14(12):2136-44. PubMed ID: 17189539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.
    Zancai P; Dal Col J; Piccinin S; Guidoboni M; Cariati R; Rizzo S; Boiocchi M; Maestro R; Dolcetti R
    Oncogene; 2005 Apr; 24(15):2483-94. PubMed ID: 15735731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
    Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
    Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.
    Muñoz U; Bartolomé F; Esteras N; Bermejo-Pareja F; Martín-Requero A
    Cell Mol Life Sci; 2008 Nov; 65(21):3507-19. PubMed ID: 18818877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis.
    Hoozemans JJ; Stieler J; van Haastert ES; Veerhuis R; Rozemuller AJ; Baas F; Eikelenboom P; Arendt T; Scheper W
    Exp Gerontol; 2006 Apr; 41(4):380-6. PubMed ID: 16564150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons.
    Akashiba H; Matsuki N; Nishiyama N
    J Neurochem; 2006 Nov; 99(3):733-44. PubMed ID: 16824045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity.
    Yang HY; Yang H; Zhao R; Lee MH
    J Cell Biochem; 2006 May; 98(1):128-38. PubMed ID: 16365885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.
    Wilson KC; Cattel DJ; Wan Z; Rahangdale S; Ren F; Kornfeld H; Sullivan BA; Cruikshank WW; Center DM
    Cell Immunol; 2005 Sep; 237(1):17-27. PubMed ID: 16289056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
    Li L; Iwamoto Y; Berezovskaya A; Boussiotis VA
    Nat Immunol; 2006 Nov; 7(11):1157-65. PubMed ID: 17013388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial inhibition of the proteasome enhances the activity of the myelin basic protein promoter.
    Calatayud CA; García CI; Paez PM; Pasquini JM; Soto EF; Pasquini LA
    Dev Neurosci; 2009; 31(3):169-80. PubMed ID: 19145069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.